Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ITL Health Group is a global medical technology company that specializes in the design, manufacture, and distribution of innovative laboratory and blood collection devices. The company operates primarily through its ITL BioMedical division, providing high-quality safety solutions for blood banks, clinical laboratories, and healthcare providers worldwide. Its core product portfolio includes the DonorCare Needle Guard and SampLok sampling systems, which are engineered to improve procedural efficiency and reduce the risk of needle-stick injuries and contamination. Headquartered in Australia with manufacturing facilities in Malaysia, ITL serves a diverse international market across more than 50 countries. The company was previously listed on the Australian Securities Exchange before being taken private to focus on long-term strategic growth in the medical device sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ITL Laboratories.